{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T18:29:55Z","timestamp":1784917795835,"version":"3.55.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012645","name":"University of Texas at Dallas","doi-asserted-by":"publisher","award":["1S10OD026758-01"],"award-info":[{"award-number":["1S10OD026758-01"]}],"id":[{"id":"10.13039\/501100012645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012645","name":"University of Texas at Dallas","doi-asserted-by":"publisher","award":["1S10OD018005-01"],"award-info":[{"award-number":["1S10OD018005-01"]}],"id":[{"id":"10.13039\/501100012645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["CP24\/00131"],"award-info":[{"award-number":["CP24\/00131"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017189","name":"Cecil and Ida Green Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017189","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.neo.2025.101244","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T08:13:27Z","timestamp":1761725607000},"page":"101244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Identification of BET inhibitors (BETi) against solitary fibrous tumor (SFT) through high-throughput screening (HTS)"],"prefix":"10.1016","volume":"70","author":[{"given":"Jose L.","family":"Mondaza-Hernandez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6514-2419","authenticated-orcid":false,"given":"David S.","family":"Moura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3006-1360","authenticated-orcid":false,"given":"Jesus L.","family":"Marti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3131-729X","authenticated-orcid":false,"given":"Paulino","family":"Gomez-Puertas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuguang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce A.","family":"Posner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8567-7448","authenticated-orcid":false,"given":"Clark A.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonidas","family":"Bleris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7350-6916","authenticated-orcid":false,"given":"Javier","family":"Martin-Broto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7581-8294","authenticated-orcid":false,"given":"Heather N.","family":"Hayenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2025.101244_bib0001","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng.2509","article-title":"Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing","volume":"45","author":"Robinson","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neo.2025.101244_bib0002","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ng.2522","article-title":"Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors","volume":"45","author":"Chmielecki","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neo.2025.101244_bib0003","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cancergen.2016.05.071","article-title":"The NAB2\u2013STAT6 gene fusion in solitary fibrous tumor can be reliably detected by anchored multiplexed PCR for targeted next-generation sequencing","volume":"209","author":"Guseva","year":"2016","journal-title":"Cancer Genet."},{"key":"10.1016\/j.neo.2025.101244_bib0004","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bbrc.2020.03.090","article-title":"NAB2-STAT6 fusion protein mediates cell proliferation and oncogenic progression via EGR-1 regulation","volume":"526","author":"Park","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neo.2025.101244_bib0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2045-3329-3-7","article-title":"The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysis","volume":"3","author":"Park","year":"2013","journal-title":"Clin. Sarcoma Res."},{"key":"10.1016\/j.neo.2025.101244_bib0006","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S1470-2045(19)30826-5","article-title":"Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trial","volume":"21","author":"Martin-Broto","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.neo.2025.101244_bib0007","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S1470-2045(18)30676-4","article-title":"Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial","volume":"20","author":"Martin-Broto","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.neo.2025.101244_bib0008","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/690251","article-title":"Solitary fibrous tumors and So-called hemangiopericytoma","volume":"2012","author":"Penel","year":"2012","journal-title":"Sarcoma"},{"key":"10.1016\/j.neo.2025.101244_bib0009","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1002\/cncr.26098","article-title":"Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor","volume":"117","author":"Park","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.neo.2025.101244_bib0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1158\/2159-8290.CD-17-0605","article-title":"BET proteins as targets for anticancer treatment","volume":"8","author":"Stathis","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.neo.2025.101244_bib0011","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.molcel.2005.06.027","article-title":"The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription","volume":"19","author":"Jang","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neo.2025.101244_bib0012","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12943-018-0915-9","article-title":"BRD4 and Cancer: going beyond transcriptional regulation","volume":"17","author":"Donati","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.neo.2025.101244_bib0013","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrc3256","article-title":"BET domain co-regulators in obesity, inflammation and cancer","volume":"12","author":"Belkina","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.neo.2025.101244_bib0014","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.molcel.2017.07.025","article-title":"The short isoform of BRD4 promotes HIV-1 latency by engaging repressive SWI\/SNF chromatin-remodeling complexes","volume":"67","author":"Conrad","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neo.2025.101244_bib0015","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-30787-6","article-title":"BRD4 promotes resection and homology-directed repair of DNA double-strand breaks","volume":"13","author":"Barrows","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2025.101244_bib0016","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13036-5","article-title":"Spatially restricted loading of BRD2 at DNA double-strand breaks protects H4 acetylation domains and promotes DNA repair","volume":"7","author":"Gursoy-Yuzugullu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neo.2025.101244_bib0017","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.celrep.2017.12.078","article-title":"BRD4 promotes DNA repair and mediates the formation of TMPRSS2-ERG gene rearrangements in prostate cancer","volume":"22","author":"Li","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.neo.2025.101244_bib0018","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073581","article-title":"Bromodomain inhibitor JQ1 provides novel insights and perspectives in rhabdomyosarcoma treatment","volume":"23","author":"Marchesi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neo.2025.101244_bib0019","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1158\/1535-7163.MCT-15-0567","article-title":"The bromodomain BET inhibitor JQ1 suppresses tumor angiogenesis in models of childhood sarcoma","volume":"15","author":"Bid","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.neo.2025.101244_bib0020","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1158\/2159-8290.CD-16-1297","article-title":"PAX3-FOXO1 establishes myogenic super enhancers and confers BET bromodomain vulnerability","volume":"7","author":"Gryder","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.neo.2025.101244_bib0021","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.18632\/oncotarget.6385","article-title":"Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma","volume":"7","author":"Hensel","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.neo.2025.101244_bib0022","article-title":"Reduction of tumor growth with RNA-targeting treatment of the NAB2-STAT6 fusion transcript in solitary fibrous tumor models","volume":"15","author":"Li","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.neo.2025.101244_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102154","article-title":"STAT6-targeting antisense oligonucleotides against solitary fibrous tumor","volume":"35","author":"Li","year":"2024","journal-title":"Mol. Ther. Nucleic. Acids."},{"key":"10.1016\/j.neo.2025.101244_bib0024","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16193374","article-title":"Triple combination of entinostat, a bromodomain inhibitor, and cisplatin is a promising treatment option for bladder cancer","volume":"16","author":"Bollmann","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.neo.2025.101244_bib0025","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.cell.2013.09.041","article-title":"Systematic identification of molecular subtype-selective vulnerabilities in non-small-cell lung cancer","volume":"155","author":"Kim","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.neo.2025.101244_bib0026","doi-asserted-by":"crossref","first-page":"aaa2340","DOI":"10.1126\/science.aaa2340","article-title":"TISSUE REGENERATION. Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration","volume":"348","author":"Zhang","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.neo.2025.101244_bib0027","doi-asserted-by":"crossref","first-page":"16951","DOI":"10.18632\/oncotarget.4773","article-title":"High-throughput simultaneous screen and counterscreen identifies homoharringtonine as synthetic lethal with von Hippel-Lindau loss in renal cell carcinoma","volume":"6","author":"Wolff","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.neo.2025.101244_bib0028","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/nbt.3419","article-title":"Improving drug discovery with high-content phenotypic screens by systematic selection of reporter cell lines","volume":"34","author":"Kang","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.neo.2025.101244_bib0029","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nchembio.2016","article-title":"Discovery of tumor-specific irreversible inhibitors of stearoyl CoA desaturase","volume":"12","author":"Theodoropoulos","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.neo.2025.101244_bib0030","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1016\/j.bmcl.2016.07.016","article-title":"Discovery of novel TAOK2 inhibitor scaffolds from high-throughput screening","volume":"26","author":"Piala","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neo.2025.101244_bib0031","doi-asserted-by":"crossref","first-page":"361ra140","DOI":"10.1126\/scitranslmed.aaf8127","article-title":"Selective targeting of mutant adenomatous polyposis coli (APC) in colorectal cancer","volume":"8","author":"Zhang","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neo.2025.101244_bib0032","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1021\/acschembio.8b00421","article-title":"High-throughput screens to identify autophagy inducers that function by disrupting beclin 1\/Bcl-2 binding","volume":"13","author":"Chiang","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.neo.2025.101244_bib0033","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/1087057107312628","article-title":"Quantitative assessment of hit detection and confirmation in single and duplicate high-throughput screenings","volume":"13","author":"Wu","year":"2008","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.neo.2025.101244_bib0034","doi-asserted-by":"crossref","first-page":"30787","DOI":"10.18632\/oncotarget.5021","article-title":"Colorectal cancer-related mutant KRAS alleles function as positive regulators of autophagy","volume":"6","author":"Alves","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.neo.2025.101244_bib0035","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.1158\/1078-0432.CCR-19-0578","article-title":"First-in-human study of Mivebresib (ABBV-075), an oral pan-inhibitor of bromodomain and extra terminal proteins, in patients with relapsed\/refractory solid tumors","volume":"25","author":"Piha-Paul","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2025.101244_bib0036","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1002\/cncr.33590","article-title":"A phase 1 study of the pan-bromodomain and extraterminal inhibitor mivebresib (ABBV-075) alone or in combination with venetoclax in patients with relapsed\/refractory acute myeloid leukemia","volume":"127","author":"Borthakur","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.neo.2025.101244_bib0037","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14174079","article-title":"BMS-986158, a small molecule inhibitor of the bromodomain and extraterminal domain proteins, in patients with selected advanced solid tumors: results from a phase 1\/2a trial","volume":"14","author":"Hilton","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.neo.2025.101244_bib0038","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/10428194.2023.2300710","article-title":"Results from phase 1 of the MANIFEST clinical trial to evaluate the safety and tolerability of pelabresib in patients with myeloid malignancies","volume":"65","author":"Stein","year":"2024","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.neo.2025.101244_bib0039","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1038\/s41401-024-01318-4","article-title":"ABBV-744 alleviates LPS-induced neuroinflammation via regulation of BATF2-IRF4-STAT1\/3\/5 axis","volume":"45","author":"Wang","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neo.2025.101244_bib0040","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1158\/1078-0432.CCR-23-1429","article-title":"Phase I results of bromodomain and extra-terminal inhibitor PLX51107 in combination with azacitidine in patients with relapsed\/refractory myeloid malignancies","volume":"29","author":"Senapati","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2025.101244_bib0041","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/ijc.33989","article-title":"Selective inhibitors of bromodomain BD1 and BD2 of BET proteins modulate radiation-induced profibrotic fibroblast responses","volume":"151","author":"Liu","year":"2022","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.neo.2025.101244_bib0042","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/sj.cdd.4400851","article-title":"Characterization of the necrotic cleavage of poly(ADP-ribose) polymerase (PARP-1): implication of lysosomal proteases","volume":"8","author":"Gobeil","year":"2001","journal-title":"Cell Death. Differ."},{"key":"10.1016\/j.neo.2025.101244_bib0043","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1023\/A:1016119328968","article-title":"Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update","volume":"7","author":"Soldani","year":"2002","journal-title":"Apoptosis"},{"key":"10.1016\/j.neo.2025.101244_bib0044","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1038\/s41467-020-16926-x","article-title":"DNA double-strand breaks induce H2Ax phosphorylation domains in a contact-dependent manner","volume":"11","author":"Collins","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2025.101244_bib0045","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1074\/jbc.273.10.5858","article-title":"DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139*","volume":"273","author":"Rogakou","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neo.2025.101244_bib0046","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a012716","article-title":"DNA damage sensing by the ATM and ATR kinases","volume":"5","author":"Mar\u00e9chal","year":"2013","journal-title":"Cold. Spring. Harb. Perspect. Biol."},{"key":"10.1016\/j.neo.2025.101244_bib0047","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1073\/pnas.1213394110","article-title":"DNA damage in stem cells activates p21, inhibits p53, and induces symmetric self-renewing divisions","volume":"110","author":"Insinga","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neo.2025.101244_bib0048","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1158\/0008-5472.CAN-09-0913","article-title":"Cyclin D1 degradation is sufficient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells","volume":"69","author":"Masamha","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2025.101244_bib0049","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1476-4598-6-24","article-title":"The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention","volume":"6","author":"Alao","year":"2007","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.neo.2025.101244_bib0050","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0968-0004(98)01232-8","article-title":"Role of the human RAD51 protein in homologous recombination and double-stranded-break repair","volume":"23","author":"Baumann","year":"1998","journal-title":"Trends. Biochem. Sci."},{"key":"10.1016\/j.neo.2025.101244_bib0051","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/ijc.30764","article-title":"RAD51 as a potential surrogate marker for DNA repair capacity in solid malignancies","volume":"141","author":"Gachechiladze","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.neo.2025.101244_bib0052","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16173016","article-title":"The potential for targeting G(2)\/M cell cycle checkpoint kinases in enhancing the efficacy of radiotherapy","volume":"16","author":"Melia","year":"2024","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.neo.2025.101244_bib0053","doi-asserted-by":"crossref","first-page":"463","DOI":"10.5732\/cjc.011.10111","article-title":"PARP inhibitors: its role in treatment of cancer","volume":"30","author":"Chen","year":"2011","journal-title":"Chin. J. Cancer"},{"key":"10.1016\/j.neo.2025.101244_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107518","article-title":"Discovery of ATR kinase inhibitor berzosertib (VX-970, M6620): clinical candidate for cancer therapy","volume":"210","author":"Gorecki","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neo.2025.101244_bib0055","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.1158\/0008-5472.CAN-18-0484","article-title":"EWS\/ETS-Driven ewing sarcoma requires BET bromodomain proteins","volume":"78","author":"Gollavilli","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2025.101244_bib0056","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1002\/1878-0261.13195","article-title":"FET fusion oncoproteins interact with BRD4 and SWI\/SNF chromatin remodelling complex subtypes in sarcoma","volume":"16","author":"Lind\u00e9n","year":"2022","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.neo.2025.101244_bib0057","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1158\/2767-9764.CRC-22-0518","article-title":"Targeting the clear cell sarcoma oncogenic driver fusion gene EWSR1::ATF1 by HDAC inhibition","volume":"3","author":"Mae","year":"2023","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.neo.2025.101244_bib0058","doi-asserted-by":"crossref","first-page":"7309","DOI":"10.1002\/jcb.28005","article-title":"BET inhibitors reduce cell size and induce reversible cell cycle arrest in AML","volume":"120","author":"Zhang","year":"2019","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.neo.2025.101244_bib0059","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.molcel.2015.04.011","article-title":"BET bromodomain inhibition suppresses the function of hematopoietic transcription factors in acute myeloid leukemia","volume":"58","author":"Roe","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neo.2025.101244_bib0060","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1101\/gad.306464.117","article-title":"A mechanism for epigenetic control of DNA replication","volume":"32","author":"Sansam","year":"2018","journal-title":"Genes Dev."},{"key":"10.1016\/j.neo.2025.101244_bib0061","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1038\/s41388-018-0194-3","article-title":"BRD4 facilitates replication stress-induced DNA damage response","volume":"37","author":"Zhang","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.neo.2025.101244_bib0062","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1101\/gad.331231.119","article-title":"Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity","volume":"33","author":"Kim","year":"2019","journal-title":"Genes Dev."},{"key":"10.1016\/j.neo.2025.101244_bib0063","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/modpathol.2015.70","article-title":"Solitary fibrous tumors: loss of chimeric protein expression and genomic instability mark dedifferentiation","volume":"28","author":"Dagrada","year":"2015","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.neo.2025.101244_bib0064","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16061125","article-title":"Therapeutic potential of bromodomain and extra-terminal domain inhibitors for synovial sarcoma cells","volume":"16","author":"Kotani","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.neo.2025.101244_bib0065","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ebiom.2019.05.035","article-title":"The BET inhibitor JQ1 attenuates double-strand break repair and sensitizes models of pancreatic ductal adenocarcinoma to PARP inhibitors","volume":"44","author":"Miller","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.neo.2025.101244_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108166","article-title":"BRD4 prevents R-Loop formation and transcription-replication conflicts by ensuring efficient transcription elongation","volume":"32","author":"Edwards","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.neo.2025.101244_bib0067","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109797","article-title":"Bromodomain protein BRD4 directs mitotic cell division of mouse fibroblasts by inhibiting DNA damage","volume":"27","author":"Wu","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.neo.2025.101244_bib0068","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1016\/j.celrep.2017.11.095","article-title":"BET bromodomain inhibition synergizes with PARP inhibitor in epithelial ovarian cancer","volume":"21","author":"Karakashev","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.neo.2025.101244_bib0069","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.1038\/onc.2015.521","article-title":"BET bromodomain inhibitors synergize with ATR inhibitors to induce DNA damage, apoptosis, senescence-associated secretory pathway and ER stress in Myc-induced lymphoma cells","volume":"35","author":"Muralidharan","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.neo.2025.101244_bib0070","doi-asserted-by":"crossref","first-page":"e2982","DOI":"10.1038\/cddis.2017.383","article-title":"BET bromodomain inhibitors synergize with ATR inhibitors in melanoma","volume":"8","author":"Muralidharan","year":"2017","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.neo.2025.101244_bib0071","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/onc.2017.299","article-title":"Nuclear factor E2-related factor-2 has a differential impact on MCT1 and MCT4 lactate carrier expression in colonic epithelial cells: a condition favoring metabolic symbiosis between colorectal cancer and stromal cells","volume":"37","author":"Diehl","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.neo.2025.101244_bib0072","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00109-019-01815-8","article-title":"Molecular changes in solitary fibrous tumor progression","volume":"97","author":"Park","year":"2019","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.neo.2025.101244_bib0073","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/cam4.572","article-title":"The clinicopathological significance of NAB2-STAT6 gene fusions in 52 cases of intrathoracic solitary fibrous tumors","volume":"5","author":"Huang","year":"2016","journal-title":"Cancer Med."},{"key":"10.1016\/j.neo.2025.101244_bib0074","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13205237","article-title":"Evaluation of NAB2-STAT6 fusion variants and other molecular alterations as prognostic biomarkers in a case series of 83 solitary fibrous tumors","volume":"13","author":"Salguero-Aranda","year":"2021","journal-title":"Cancers. (Basel)"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558625001241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558625001241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T20:35:06Z","timestamp":1773261306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558625001241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":74,"alternative-id":["S1476558625001241"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2025.101244","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of BET inhibitors (BETi) against solitary fibrous tumor (SFT) through high-throughput screening (HTS)","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2025.101244","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101244"}}